| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.4M | — |
| Cost of Revenue | $29.5M | — |
| Gross Profit | -$20.2M | — |
| R&D Expense | $140.7M | +75.0% |
| SG&A Expense | $85.3M | +14.1% |
| Operating Income | -$418.9M | -163.0% |
| Pre-tax Income | -$411.4M | -59.4% |
| Income Tax | $0 | +100.0% |
| Net Income | -$411.4M | -59.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.6M | -89.6% |
| Short-term Investments | $69.2M | — |
| Accounts Receivable | $5.3M | +193.3% |
| Inventory | $6.8M | -11.4% |
| Current Assets | $125.8M | -63.7% |
| Total Assets | $174.7M | -65.0% |
| Current Liabilities | $81.5M | +100.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$175.4M | -53.4% |
| Capital Expenditures | $47.6M | +24.2% |
| Investing Cash Flow | -$117.4M | -92.2% |
| Financing Cash Flow | $1.4M | -99.7% |
| Free Cash Flow | -$223.1M | -46.1% |
| Long-term Debt |
| $0 |
| — |
| Total Liabilities | $92.4M | +47.8% |
| Stockholders' Equity | $82.3M | -81.1% |